Propanc Biopharma, Inc. (PPCB) stock
Close on Nov 13, 2026Market cap $12.29MP/E –Yield –
Propanc Biopharma statistics
66 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.31
- 2.22
Share statisticsIndustry
- Shares Change (QoQ)
- -84.9%
- 0.50%
- Float
- 6M
- 49M
- Shares Held by Insiders
- 0.00%
- 11.7%
- Shares Held by Institutions
- 0.76%
- 56.4%
Short sellingIndustry
- Short Interest
- 19,745
- –
- Short Interest Change
- -60.9%
- -0.80%
- Short % of Float
- 0.31%
- 9.01%
- Short % of Shares Outstanding
- 0.31%
- 6.30%
- Days to Cover
- 1.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $228.30
- –
- 52-Week Low
- $0.31
- –
- 20-Day Moving Average
- $2.04
- –
- 50-Day Moving Average
- $3.11
- –
- 200-Day Moving Average
- $9.15
- –
- Average True Range (14)
- $0.86
- –
- Price Change (1 Week)
- 9.66%
- -1.15%
- Price Change (1 Month)
- 468.3%
- -4.87%
- Price Change (3 Months)
- -83.1%
- -21.0%
- Price Change (6 Months)
- 14.2%
- -20.6%
- Price Change (YTD)
- -85.5%
- -23.6%
- Price Change (1 Year)
- -90.7%
- -22.4%
- Price Change (3 Years)
- 165.9%
- -29.5%
- Price Change (5 Years)
- -99.9%
- -77.9%
- Price Change (10 Years)
- -100.0%
- -65.4%
- Average Volume (10 Days)
- 16,997
- –
- Average Volume (20 Days)
- 39,994
- –
- Average Volume (90 Days)
- 211,351
- –
- Relative Volume
- 0.05
- 0.70
- Relative Strength Index (14)
- 48.0
- 43.4
- Volatility (1 Year)
- 4717.8%
- 80.1%
Returns on capitalIndustry
- Return on Equity (ROE)
- -161.9%
- -49.9%
- Return on Assets (ROA)
- -116.4%
- -40.6%
- Return on Invested Capital (ROIC)
- -127.9%
- -32.9%
- Return on Capital Employed (ROCE)
- -192.9%
- -37.9%
Financial positionIndustry
- Current Ratio
- 2.55
- 3.30
- Quick Ratio
- 0.25
- 2.39
- Interest Coverage
- -42.24
- -6.35
EfficiencyIndustry
- Profits Per Employee
- -$9.43M
- -$689.41K
- Employee Count
- 2
- 74
Income statement (TTM)Industry
- Pretax Income
- -$18.86M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $832.01K
- $17.76M
- Net Cash Per Share
- $0.13
- $0.80
- Equity (Book Value)
- $9.40M
- $53.89M
- Book Value Per Share
- $1.48
- $1.50
- Tangible Book Value
- $9.40M
- $27.13M
- Working Capital
- $5.19M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$4.93K
- -$1.00M
- FCF Per Share
- -$0.90
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -153.5%
- -21.8%
- FCF Yield
- -46.3%
- -9.44%
- Buyback Yield
- -27.0%
- -0.76%
- Shareholder Yield
- -27.0%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $430.54K
- $2.90M
Scores and fair valueIndustry
- Altman Z-Score
- -17.85
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | PPCB | S&P 500 | Difference | PPCB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +370.5% | -3.0% | +373.6 pts | ||
| 3 months | -84.1% | -2.8% | −81.3 pts | ||
| Year to date | -85.5% | +11.5% | −97.0 pts | ||
| 1 year | -90.1% | +13.5% | −103.5 pts | ||
| 3 years | +256.1% | +77.7% | +178.4 pts | +52.7% | +21.1% |
| 5 years | -99.9% | +72.6% | −172.5 pts | -73.6% | +11.5% |
| 10 years | -100.0% | +308.2% | −408.2 pts | -91.2% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M PPCB shares were sold short on Oct 30, 2026, down 60.9% from the previous report, or 0.31% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 46.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 19,745 | -60.9% | 57,444 | 1.0 |
| Oct 15, 2026 | 50,470 | -29.1% | 285,386 | 1.0 |
| Sep 30, 2026 | 71,162 | +145.4% | 333,944 | 1.0 |
| Sep 15, 2026 | 29,003 | -91.4% | 298,214 | 1.0 |
| Aug 31, 2026 | 335,967 | +497.2% | 9,115,538 | 1.0 |
| Aug 14, 2026 | 56,255 | +179.2% | 235,824 | 1.0 |
| Jul 31, 2026 | 20,152 | -84.9% | 99,223 | 1.0 |
| Jul 15, 2026 | 133,524 | +689.9% | 5,925,509 | 1.0 |
| Jun 30, 2026 | 16,903 | -95.2% | 206,327 | 1.0 |
| Jun 15, 2026 | 352,559 | +1030.0% | 15,852,470 | 1.0 |
| May 29, 2026 | 31,201 | -94.9% | 90,333 | 1.0 |
| May 15, 2026 | 617,010 | +17.8% | 1,040,060 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?